In vitro–in vivoextrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Although the measurement of metabolite formation or substrate depletion in in vitro systems, from recombinant enzymes to tissue slices, is a relatively routine task, there are a number of more or less unresolved issues in the extrapolation of the enzymatic intrinsic clearance into hepatic metabolic clearance. Nominal concentrations of the drug added to the incubation system are not necessarily the concentration the transporter or the metabolizing enzyme sees. In addition, peculiarities of incubation set-ups should be assessed. Unbound drug fractions (concentrations) in the in vitro system itself should be measured or estimated for the appropriate assessment of enzymatic intrinsic clearance. In addition, blood and/or plasma concentrations to be encountered in the in vivo situation should be measured or estimated for the extrapolation. Extrapolation always means making a number of assumptions and the most important of these, such as scaling factors from recombinant enzymes, microsomes or hepatocytes to the mass unit of the liver, liver weight, blood flow, and distribution volume amongst others, and so on, should be explicitly stated and included in the extrapolation process. Despite all the above-mentioned reservations the in vitro-in vivo extrapolation of metabolic clearance seems to be a useful and mostly fairly precise tool for predicting the important pharmacokinetic processes of a drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obach, R. S. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14938-0 · Cited by 1,232
Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
Brian Houston, J. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90520-7 · Cited by 925
Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735 · cited 2×
“However, it should be emphasized that cultured hepatocytes are a good and reliable model for predicting CYP induction only when maintained under optimal experimental conditions (Li et al. 1997; Kostrubsky et al. 1999; LeCluyse 2001; Worboys and Carlile 2001; Gomez-Lechon et al. 2003, 2004; Hewitt et al. 2007).”
BackgroundPrediction of in vivo drug metabolism in the human liver from in vitro metabolism data
Iwatsubo, T., Hirota, N., Ooie, T., Suzuki, H., Shimada, N., Chiba, K., Ishizaki, T., Green, C. E., Tyson, C. A., & Sugiyama, Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00184-2 · Cited by 479 · cited 2×
“Knowing that the drug concentrations in in vivo situations are usually far below their Km values, namely under linear velocity conditions, CLint is equal to the ratio of Vmax/Km (Houston 1994; Iwatsubo et al. 1997).”
BackgroundLeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Barter, Z., Bayliss, M., Beaune, P., Boobis, A., Carlile, D., Edwards, R., Brian Houston, J., Lake, B., Lipscomb, J., Pelkonen, O., et al. (2007) · Current Drug Metabolism · doi:10.2174/138920007779315053 · Cited by 459 · cited 2×
“…factor MPPGL. Widely different values for MPPGL have been used over the years, many of them based on rat data and not human data, but in a very recent meta-analysis by Barter et al. (2007) a value of 32 mg g–1 (95% confidence interval (CI); 29–34 mg g–1) for human liver for MPPGL has been reported.”
BackgroundMethodSelf-citationAustin, R. P., Barton, P., Cockroft, S. L., Wenlock, M. C., & Riley, R. J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.12.1497 · Cited by 413
Standard liver volume in the caucasian population
Heinemann, A., Wischhusen, F., Püschel, K., & Rogiers, X. (1999) · Liver Transplantation and Surgery · doi:10.1002/lt.500050516 · Cited by 246 · cited 1×
“A value of 1500 g in man has usually been employed, although there are recent meta-analyses on the liver size in different ethnic population (Murry et al. 1995; Urata et al. 1995; Heinemann et al. 1999; Johnson et al. 2005).”
MethodLavé, T., Dupin, S., Schmitt, C., Valles, B., Ubeaud, G., Chou, R. C., Jaeck, D., & Coassolo, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012036324237 · Cited by 106 · cited 1×
“In some studies albumin or serum was purposefully added into the medium to mimic in vivo conditions (Lave et al. 1997; Shibata et al. 2002), but this modification has not been widely accepted (Grime and Riley 2006).”
BackgroundPrediction of metabolic drug clearance in humans:In vitro–in vivoextrapolationvsallometric scaling
Shiran, M. R., Proctor, N. J., Howgate, E. M., Rowland-Yeo, K., Tucker, G. T., & Rostami-Hodjegan, A. (2006) · Xenobiotica · doi:10.1080/00498250600761662 · Cited by 89 · cited 1×
“Details of various models and equations can be found in recent reviews (Houston and Galetin 2003; Shiran et al. 2006).”
Background
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010
Adler, S., Basketter, D., Creton, S., Pelkonen, O., van Benthem, J., Zuang, V., Andersen, K. E., Angers-Loustau, A., Aptula, A., Bal-Price, A., et al. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0693-2 · Cited by 584
Self-citationThe Simcyp ® Population-based ADME Simulator
Jamei, M., Marciniak, S., Feng, K., Barnett, A., Tucker, G., & Rostami-Hodjegan, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802691074 · Cited by 533
“Both of these databases are incomplete, fragmented and of variable reliability [60,61] .”
BackgroundFundamentals of Enzyme Kinetics
Seibert, E., & Tracy, T. S. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-62703-758-7_2 · Cited by 370
Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results
Yoon, M., Campbell, J. L., Andersen, M. E., & Clewell, H. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.692115 · Cited by 216
“Therefore, QIVIVE for drug metabolism has largely focused on prediction of oral bioavailability and metabolic stability screening to inform the drug’s half-life (Pelkonen and Turpeinen, 2007; Houston and Galetin, 2008).”
BackgroundMethod
Metadata
- Authors
- Pelkonen, O., & Turpeinen, M.
- Venue
- Xenobiotica
- Publisher
- Informa UK Limited
- Published
- 2007-11
- Volume
- 37
- Issue
- 10-11
- Pages
- 1066-1089
- ISSN
- 0049-8254 (ISSN-L)
- 1366-5928
- OpenAlex
- W2006532982
- Cited by
- 119
- References
- 11
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vitro–in vivoextrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations. https://app.cochat.ai/papers/10.1080/00498250701620726
- The paper
- Pelkonen, O., & Turpeinen, M. (2007). In vitro–in vivoextrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations. Xenobiotica. https://doi.org/10.1080/00498250701620726
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.